OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 116 filers reported holding OPHTHOTECH CORP in Q4 2014. The put-call ratio across all filers is 1.40 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $44,734,000 | -38.5% | 1,103,981 | -21.0% | 25.02% | -10.2% |
Q2 2015 | $72,742,000 | -23.9% | 1,397,256 | -31.9% | 27.85% | -11.8% |
Q1 2015 | $95,533,000 | -18.8% | 2,053,143 | -21.7% | 31.57% | -46.2% |
Q4 2014 | $117,630,000 | -8.7% | 2,621,575 | -20.8% | 58.70% | -8.7% |
Q3 2014 | $128,807,000 | -8.0% | 3,308,695 | 0.0% | 64.27% | -18.3% |
Q2 2014 | $139,991,000 | – | 3,308,695 | – | 78.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JHL Capital Group LLC | 3,265,000 | $166,613,000 | 20.59% |
Novo Holdings A/S | 3,610,487 | $184,243,000 | 19.34% |
Green Owl Capital Management, LLC | 847 | $834,000 | 5.16% |
Ghost Tree Capital, LLC | 215,000 | $10,971,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $822,000 | 2.76% |
IMA Wealth, Inc. | 57,131 | $2,867,000 | 1.80% |
Slate Path Capital LP | 430,000 | $21,943,000 | 1.72% |
Signpost Capital Advisors, LP | 50,587 | $2,581,000 | 1.36% |
Orbimed Advisors | 2,148,100 | $109,618,000 | 1.14% |
PURA VIDA INVESTMENTS, LLC | 52,500 | $2,679,000 | 1.14% |